Quasar Medical announced that it completed the acquisition of Ridgeback Technologies, a maker of cutting-edge catheter balloons. The company says Galway, Ireland-based Ridgeback's offerings enhance its full-service portfolio of minimally invasive medical devices. The company provides end-to-end manufacturing solutions for such devices and now … [Read more...] about Quasar Medical acquires balloon maker Ridgeback Technologies
Neurology
Neurovascular tech company Route 92 Medical adds $50M in funding
Route 92 Medical announced today that it added a $50 million extension to its oversubscribed Series F financing round. The extension brings the total funding in the Series F round to $82 million. Novo Holdings joined returning investors U.S. Venture Partners, Norwest Venture Partners, InnovaHealth Partners and The Vertical Group in the … [Read more...] about Neurovascular tech company Route 92 Medical adds $50M in funding
Penumbra wins CE mark for computer-assisted thrombectomy tech
Penumbra (NYSE:PEN) announced today that it received CE mark approval for its computer-assisted vacuum thrombectomy (CAVT) technologies. The Lightning Flash 2.0 and Lightning Bolt 7 offerings from the Alameda, California-based company both picked up European approval. Penumbra said approval makes its Lightning products the only CAVT systems … [Read more...] about Penumbra wins CE mark for computer-assisted thrombectomy tech
Scientia Vascular raises $14M for neurovascular treatment tech
Scientia Vascular announced today the successful completion of a $14 million growth financing round. West Valley City, Utah–based Scientia says the money will enable it to continue commercializing what company officials describe as the next generation of neurovascular tools, providing new ways to treat a variety of neurovascular disease … [Read more...] about Scientia Vascular raises $14M for neurovascular treatment tech
Penumbra announces $200M share repurchase program
Penumbra (NYSE:PEN) announced today that its board of directors approved a share repurchase authorization of up to $200 million. Alameda, California-based Penumbra said in a news release that its board approved the repurchase on Aug. 5. It allows the company to repurchase its common stock from time to time at such prices as it deems appropriate. … [Read more...] about Penumbra announces $200M share repurchase program
Imperative Care has positive stroke treatment data
Imperative Care today announced positive data from a study of its Zoom reperfusion system for the treatment of ischemic stroke. Dr. William Mack, co-principal investigator, presented the results at the Society of NeuroInterventional Surgery (SNIS) annual meeting. The study evaluated 260 patients across 26 U.S. institutions between … [Read more...] about Imperative Care has positive stroke treatment data
Imperative Care wins FDA nod for stroke catheter
Imperative Care announced today that the FDA granted 510(k) clearance for its Zoom 6F insert catheters for ischemic stroke procedures. The company also announced the successful completion of the first case with the Zoom 6F insert catheters. Dr. Dana Tomalty performed the case at Huntsville Hospital in Huntsville, Alabama. Tomalty used the … [Read more...] about Imperative Care wins FDA nod for stroke catheter
InspireMD brings in $17.9M to support stent trial
InspireMD (Nasdaq:NSPR) announced today that it completed a full exercise of Series H warrants for proceeds of about $17.9 million. Tel Aviv, Israel-based InspireMD exercised 12.9 million warrants, converting primarily into pre-funded warrants. The gross proceeds for the company, which has a U.S. base in Westin, Florida, total $16.9 million … [Read more...] about InspireMD brings in $17.9M to support stent trial
Penumbra launches duo of stroke catheters in Europe
Penumbra (NYSE:PEN) announced today that, with CE mark approval, it launched its new BMX81 and BMX96 neuro access devices in Europe. The company designed the devices for the neurovascular management of ischemic and hemorrhagic stroke. Penumbra said they represent its "most advanced neuro access offerings," according to a news release. The launch … [Read more...] about Penumbra launches duo of stroke catheters in Europe
FDA says recall of Cerenovus catheter guide sheaths is serious
The FDA deemed a recall of catheter guide sheaths from Johnson & Johnson’s (NYSE:JNJ) Cerenovus Class I, the most serious kind. Medos International Sàrl, a J&J unit, recalled the Cerenovus Cerebase DA guide sheath and single-use neurovascular guide catheter on Feb. 2, 2024. The company distributed the devices — 1,343 in total — between … [Read more...] about FDA says recall of Cerenovus catheter guide sheaths is serious
